Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Golden Meditech Announces FY2016/2017 Interim Results

      Proactively Adjusts Marketing Strategy to Cope with the Fluctuation in Medical Devices Business

      Development of Healthcare Services Business On-track, Sunbow O&G Hospital to Contribute New Momentum


      News provided by

      Golden Meditech Holdings Limited

      Nov 23, 2016, 07:06 ET

      Share this article

      Share this article


      HONG KONG, Nov. 23, 2016 /PRNewswire/ --

      Continuing Operations

      For the Six Months Ended 30 September


      2016

      (HK$'000)

      2015

      (HK$'000)

      Change

      (%)

      Revenue

      121,672

      150,527

      (19.2)

      Healthcare services segment revenue

      31,885

      31,129

      2.4

         Hospital management services income

      29,901

      28,349

      5.5

         Medical insurance administration services income 

      1,984

      2,780

      (28.6)

      Medical devices segment revenue

      87,615

      116,576

      (24.8)

      Strategic investments revenue

      2,172

      2,822

      (23.0)

      Gross profit

      61,784

      66,599

      (7.2)

      Loss before interest, tax, depreciation and amortisation, fair value changes in financial assets and financial liabilities

      (113,082)

      (74,132)

      52.5

      Loss attributable to the Company's equity shareholders

      (317,154)

      (138,275)

      129.4

      Adjusted loss attributable to the Company's equity shareholders*

      (166,752)

      (138,275)

      20.6

      Basic loss per share (in HK cents)

      (10.69)

      (7.36)

      45.2

      Adjusted basic loss per share* (in HK cents)

      (5.62)

      (7.36)

      (23.6)


      * Excluding interests incurred on promissory notes.

      Golden Meditech Holdings Limited (SEHK stock code: 00801, TWSE stock code: 910801) ("Golden Meditech" or the "Company", together with its subsidiaries, the "Group"), a leading integrated healthcare enterprise in China, announces today its interim results for the period ended 30 September 2016 (the "Reporting Period").

      During the Reporting Period, the results from continuing operations were in line with the management's expectations. The Group's total revenue from continuing operations was HK$121,672,000, decreased by 19.2% year-on-year. Of which, revenue from the healthcare services segment and the medical devices segment accounted for 26.2% and 72.0% of the Group's total revenue from continuing operations, respectively. The decline in total revenue from continuing operations was mainly attributable to the 24.8% year-on-year decrease in medical devices revenue. Loss attributable to equity shareholders of the Company from continuing operations increased by 129.4% year-on-year to HK$317,154,000. Such increase was mainly attributable to the interests incurred on the issuance of US$250,000,000 (approximately HK$1,940,000,000) promissory notes in December 2015; the Company used this financing to increase its interests in China Cord Blood Corporation ("CCBC"). Basic loss per share was 10.69 HK cents, increased by 45.2% year-on-year. Excluding the related interests expense, the adjusted loss attributable to equity shareholders of the Company from continuing operations was HK$166,752,000, representing a year-on-year increase of 20.6% and the adjusted basic loss per share was 5.62 HK cents, a year-on-year decrease of 23.6%.  

      Mr. Kam Yuen, Chairman and Chief Executive Officer of the Group, said, "Though the global economy slows down, China still maintains a stable economy growth so far in 2016, thanks to the structural adjustments and stable economy growth policies. Driven by aging population and industrial policies, Chinese healthcare services sector has flourished. Its annualised growth rate is expected to surpass the macro-economy growth rate, making the healthcare services sector one of the most attractive sectors. The government introduces favourable measures to promote the development of non-public medical institutions. As a leading integrated healthcare enterprise in China, the Group pays close attention to the changes in Chinese economy and regulations, aiming to provide premium healthcare services and quality medical devices."

      The Company submitted a non-binding privatisation proposal to the board of directors of CCBC (the "Proposed Privatisation") in April 2015. During the process of the Proposed Privatisation, the Group was approached by Nanjing Xinjiekou Department Store Co., Ltd. ("Nanjing Xinbai") in respect of the disposal of its 65.4% equity interest in CCBC. The disposal was approved by the Company's shareholders on 15 June 2016. In view of the uncertainty in the current regulatory policy regarding significant asset restructuring of listed companies in the PRC, consequently, Nanjing Xinbai decided to withdraw the application for the CSRC's approval of its acquisition of CCBC shares on 29 August 2016. Nevertheless, Nanjing Xinbai might participate in the future sale and purchase of the CCBC shares in accordance with other relevant regulatory policies. Subsequently, on 1 September 2016, the Company entered into an earnest money agreement with Sanpower Group Limited ("Sanpower"), the substantial shareholder of Nanjing Xinbai. Pursuant to the agreement, Sanpower agreed to deposit an earnest money of RMB300,000,000 (approximately HK$348,867,000) so as to secure alternative arrangements for the future sale and purchase of the CCBC shares.

      Moreover, the Company made a full impairment provision of HK$759,934,000 (the "Impairment Provision") against its investment in Fortress Group Limited ("Fortress", a former associate of the Group) in the 2014/2015 fiscal year. The management is committed to maximising returns for its shareholders. Through several constructive negotiations, the Company entered into settlement agreements with each of PAG Asia I LP and its assignee PAGAC Fortress Holding I Limited and Sanpower. It is expected that the conclusions of the two settlement arrangements will bring approximately US$120,000,000 (approximately HK$930,000,000) to the Group, which exceeds the Impairment Provision. Such two settlement agreements are subject to the approval of the Company's shareholders.

      Mr. Kam Yuen continued, "During the Reporting Period, the Group is still undergoing business strategies transformation. Whilst our healthcare services segment delivers business development as expected, our medical devices segment faces challenges. Importantly, the Group is determined to seek investment opportunities in the broad healthcare market. As such, the Company teamed up with The University of Texas at MD Anderson Cancer Center in the U.S.A. and an independent strategic investor to establish Cellenkos Inc., which focuses on umbilical cord blood derived T-regulatory cellular therapies. The Group will actively integrate its existing resources so as to improve its overall competitiveness."

      Continuing Operations

      Healthcare Services Segment

      During the Reporting Period, healthcare services revenue increased by 2.4% year-on-year to HK$31,885,000, accounting for 26.2% of total revenue from continuing operations. Revenue generated from hospital management business and medical insurance administration business were HK$29,901,000 and HK$1,984,000, accounting for 93.8% and 6.2% of healthcare services revenue respectively.

      Hospital Management Business. Beijing Qinghe Hospital ("Qinghe Hospital") obtained its license in late 2015, and Beijing Sunbow Obstetrics & Gynecology Hospital ("Sunbow O&G Hospital") was officially opened in October 2016. Over the years, leveraging on its well-known brand and sound reputation, Shanghai East International Medical Center ("SEIMC") had achieved a steady development and provided premium healthcare services to the affluent people in Shanghai and the surrounding neighbourhoods. During the Reporting Period, SEIMC made revenue growth contribution to the hospital management business. The management believes the revenue, profit and cash flow of Qinghe Hospital will improve progressively once it is fully operational.

      Medical Insurance Administration Business. The Group's self-developed claim administration system continues to gain recognition and accreditation by the market and end users. This has helped the Group in building a sound reputation in the insurance sector while expanding its sales channels. The management expects that the Group will explore more collaboration opportunities with insurance companies while its self-developed claim administration system obtained broader recognition. As a result, the Group will enhance its operational efficiency as well as its profitability.

      Medical Devices Segment

      Medical devices revenue decreased by 24.8% year-on-year to HK$87,615,000, accounting for 72.0% of total revenue from continuing operations. The decrease was mainly attributable to the increasing competition in the medical devices market. The Group proactively adjusted its marketing strategy and lowered its Autologous Blood Recovery System selling price in order to cushion the decrease in the sales of medical device consumables. The management expects that the decline in the medical devices revenue will gradually improve as the Group adjusts its marketing strategy to cope with the intensifying market competition.

      Strategic Investments

      The Chinese herbal medicines business recorded an operating loss of HK$11,620,000 during the Reporting Period. The Group received a potential land resumption request from the local government in Qingpu District of Shanghai in April 2016. The Group is negotiating with the relevant regulatory department regarding the land valuation and expects to improve its cash position if the land resumption is successful.  

      Cord Blood Storage Business -- Discontinuing Operation

      During the Reporting Period, revenue from the discontinuing operation decreased slightly by 0.5% year-on-year to HK$419,785,000, which was largely attributable to the depreciation of Renminbi. Excluding the impact of the depreciation of Renminbi, the revenue in fact increased by 6.0% year-on-year. Profit from discontinuing operation amounted to HK$135,481,000. No depreciation and amortisation were charged on the assets of the discontinuing operation subsequent to the reclassifications as "assets of disposal group classified as held for sale" on 31 March 2016. Excluding depreciation & amortisation and fair value changes of financial liabilities, the adjusted profit from discontinuing operation during the corresponding period last year was HK$135,608,000, which represents insignificant fluctuation when compared to the Reporting Period.


      For the Six Months Ended 30 September

      2016

      (HK$'000)

      2015

      (HK$'000)

      Revenue

      419,785

      421,979

      Gross profit

      349,952

      329,258

      Other income

      11,241

      24,885

      Selling and administrative expenses

      (194,731)

      (202,511)

      Impairment loss on available-for-sale equities securities

      -

      (10,474)

      Profit from operations

      166,462

      141,158

      Finance costs

      (1,727)

      (1,816)

      Changes in fair value of financial liabilities at fair value through profit or loss

      -

      (333,176)

      Profit/(loss) before tax

      164,735

      (193,834)

      Income tax expense

      (29,254)

      (35,506)

      Profit/(loss) from discontinuing operation

      135,481

      (229,340)

      Outlook

      Looking ahead, Mr. Kam commented, "As a leading integrated healthcare enterprise in China, we will continue to closely monitor the healthcare reforms, apply synergies from the medical devices business to complement the growth of our premium healthcare services business, and unearth the potentials of every business segments. We are committed to improving the operating performance of the Group and create value for shareholders."

      About Golden Meditech Holdings Limited (SEHK stock code: 00801, TWSE stock code: 910801)

      Golden Meditech (www.goldenmeditech.com) is a leading integrated-healthcare enterprise in China. It is a first-mover in China, having established its dominant positions in several markets including the medical devices market, the cord blood storage market and the hospital management market in the healthcare industry, thanks to its strengths in innovation and market expertise and the ability to capture emerging market opportunities. Going forward, Golden Meditech will continue to pursue a leading position in China's healthcare industry both through organic growth and strategic expansion.

      SEGMENT RESULTS

      Information regarding the Group's reportable segments for the periods ended 30 September 2016 and 2015 is set out below:

      (HK$'000 )

      Continuing

      Operations

      Discontinuing Operation

      Total

      Medical Devices

      Hospital Management

      Medical Insurance
      Administration

      Chinese Herbal
      Medicines

      Cord Blood

      Storage

      2016

      2015

      2016

      2015

      2016

      2015

      2016

      2015

      2016

      2015

      2016

      2015

      Revenue from External Customers

      69,390

      89,645

      29,901

      28,349

      1,984

      2,780

      2,172

      2,822

      419,785

      421,979

      523,232

      545,575

      Inter-segment Revenue

      18,225

      26,931

      --

      --

      --

      --

      --

      --

      --

      --

      18,225

      26,931

      Reportable Segment Revenue

      87,615

      116,576

      29,901

      28,349

      1,984

      2,780

      2,172

      2,822

      419,785

      421,979

      541,457

      572,506

      Reportable Segment Profit/(Loss)

      24,988

      33,023

      (62,883)

      (69,649)

      (19,214)

      (17,357)

      (11,620)

      (12,844)

      166,462

      141,350

      97,733

      74,523

      SOURCE Golden Meditech Holdings Limited

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.